Discontinuation of Vasopressin Before Norepinephrine in the Recovery Phase of Septic Shock

Abstract

Background:

Guidance for the discontinuation of vasopressors in the recovery phase of septic shock is limited. Norepinephrine is more easily titrated; however, septic shock is a vasopressin deficient state, which exogenous vasopressin endeavors to resolve. Discontinuation of vasopressin before norepinephrine may result in clinically significant hypotension.

Methods:

This retrospective, cohort study compared discontinuation of norepinephrine and vasopressin in medically, critically ill patients in the recovery phase of septic shock from May 2014 to June 2016. Difference in clinically significant hypotension after norepinephrine or vasopressin discontinuation was evaluated with χ² test. Linear regression was performed, examining the effect of agent discontinuation on clinically significant hypotension. Baseline variables were examined for a bivariate relationship with clinically significant hypotension; those with P < .2 were included in the model.

Results:

Vasopressin was discontinued first or last in 62 and 92 patients, respectively. Sequential Organ Failure Assessment scores at 72 hours (7.9 vs 7.6, P = .679) were similar. In unadjusted analysis, when vasopressin was discontinued first, more clinically significant hypotension developed (10.9% vs 67.8%, P < .001). There was no difference in intensive care unit (174 vs 216 hours, P = .178) or hospital duration (470 vs 473 hours, P = .977). In adjusted analyses, discontinuing vasopressin first was associated with increased clinically significant hypotension (odds ratio [OR]: 13.837, 95% confidence interval [CI]: 3.403-56.250, P < .001) but not in-hospital (OR: 0.659, 95% CI: 0.204-2.137, P = .488) or 28-day mortality (OR: 0.215, 95% CI: 0.037-1.246, P = .086).

Conclusion:

Adult patients receiving norepinephrine and vasopressin in the resolving phase of septic shock may be less likely to develop clinically significant hypotension if vasopressin is the final vasopressor discontinued.

Keywords

hypotension norepinephrine septic shock vasopressin

Get full access to this article

View all access options for this article.

References

Singer

Deutschman

Seymour

, et al.

The third international consensus definitions for sepsis and septic shock (Sepsis-3)

JAMA. 2016;315(8):801–810.

Shankar-Hari

Phillips

Levy

, et al. Developing a new definition and assessing new clinical criteria for septic shock. JAMA. 2016;315(8):775–787.

Angus

van der Poll

. Severe sepsis and septic shock. N Engl J Med. 2013;369(9):840–851.

Sharshar

Blanchard

Paillard

Raphael

Gajdos

Annane

. Circulating vasopressin levels in septic shock. Crit Care Med. 2003;31(6):1752–1758.

Russell

Walley

Singer

, et al. Vasopressin versus norepinephrine infusion in patients with septic shock. N Engl J Med. 2008;358(9):877–887.

Sharshar

Carlier

Blanchard

, et al. Depletion of neurohypophyseal content of vasopressin in septic shock. Crit Care Med. 2002;30(3):497–500.

Mutlu

Factor

. Role of vasopressin in the management of septic shock. Intensive Care Med. 2004;30(7):1276–1291.

Barrett

Singer

Clapp

. Vasopressin: mechanisms of action on the vasculature in health and in septic shock. Crit Care Med. 2007;35(1):33–40.

Bauer

Aloi

Ahrens

Yeh

Culver

Reddy

. Discontinuation of vasopressin before norepinephrine increases the incidence of hypotension in patients recovering from septic shock: a retrospective cohort study. J Crit Care. 2010;25(2):362.e7–362.e11.

10.

Rhodes

Evans

Alhazzani

, et al. Surviving Sepsis Campaign: International Guidelines for Management of Sepsis and Septic Shock: 2016. Crit Care Med. 2017;45(3):486–552. doi:10.1097/CCM.0000000000002255.

11.

Landry

Levin

Gallant

, et al. Vasopressin deficiency contributes to the vasodilation of septic shock. Circulation. 1997;95(5):1122–1125.

12.

Malay

Ashton

Jr Landry

Townsend

. Low-dose vasopressin in the treatment of vasodilatory septic shock. J Trauma. 1999;47(4):699–703.

13.

Tsuneyoshi

Yamada

Kakihana

, et al. Hemodynamic and metabolic effects of low-dose vasopressin infusions in vasodilatory septic shock. Crit Care Med. 2001;29(3):487–493.

14.

Morales

Garrido

Madigan

, et al. A double-blind randomized trial: prophylactic vasopressin reduces hypotension after cardiopulmonary bypass. Ann Thorac Surg. 2003;75(3):926–930.

15.

Whitson

Nabi

, et al. Feasibility, utility, and safety of midodrine during recovery phase from septic shock. Chest. 2016;149(6):1380–1383.

16.

Poveromo

Michalets

Sutherland

. Midodrine for the weaning of vasopressor infusions. J Clin Pharm Ther. 2016;41(3):260–265.

17.

Levine

Meyer

Bittner

, et al. Oral midodrine treatment accelerates the liberation of intensive care unit patients from intravenous vasopressor infusions. J Crit Care. 2013;28(5):756–762.

18.

Hammond

Smith

Meena

. Considerations on midodrine use in resolving septic shock. Chest. 2016;149(6):1582–1583.

19.

Leone

Asfar

Radermacher

Vincent

Martin

. Optimizing mean arterial pressure in septic shock: a critical reappraisal of the literature. Crit Care. 2015;19(1):R101.

20.

LeDoux

Astiz

Carpati

Rackow

. Effects of perfusion pressure on tissue perfusion in septic shock. Crit Care Med. 2000;28(8):2729–2732.

21.

Bourgoin

Leone

Delmas

Garnier

Albanèse

Martin

. Increasing mean arterial pressure in patients with septic shock: effects on oxygen variables and renal function. Crit Care Med. 2005;33(4):780–786.

22.

Deruddre

Cheisson

Mazoit

Vicaut

Benhamou

Duranteau

. Renal arterial resistance in septic shock: effects of increasing mean arterial pressure with norepinephrine on the renal resistive index assessed with Doppler ultrasonography. Intensive Care Med. 2007;33(9):1557–1562.

23.

Jhanji

Stirling

Patel

Hinds

Pearse

. The effect of increasing doses of norepinephrine on tissue oxygenation and microvascular flow in patients with septic shock. Crit Care Med. 2009;37(6):1961–1966.

24.

Thooft

Favory

Salgado

, et al. Effects of changes in arterial pressure on organ perfusion during septic shock. Crit Care. 2011;15(5):R222.

25.

Dubin

Pozo

Casabella

, et al. Increasing arterial blood pressure with norepinephrine does not improve microcirculatory blood flow: a prospective study. Crit Care. 2009;13(3):R92.

26.

Asfar

Meziani

Hamel

, et al. High versus low blood-pressure target in patients with septic shock. N Engl J Med. 2014;370(17):1583–1593.